Ibrutinib enhances the efficacy of ROR1 bispecific T cell engager mediated cytotoxicity in chronic lymphocytic leukaemia. (7th April 2019)

Record Type:: Journal Article
Title:: Ibrutinib enhances the efficacy of ROR1 bispecific T cell engager mediated cytotoxicity in chronic lymphocytic leukaemia. (7th April 2019)
Main Title:: Ibrutinib enhances the efficacy of ROR1 bispecific T cell engager mediated cytotoxicity in chronic lymphocytic leukaemia
Authors:: Gohil, Satyen H.
Evans, Rachel
Harasser, Micaela
El‐Kholy, Mohamed
Paredes‐Moscosso, Solange R.
Della Peruta, Marco
Nathwani, Amit C.
Abstract:
Is Part Of:: British journal of haematology. Volume 186:Number 2(2019)
Journal:: British journal of haematology
Issue:: Volume 186:Number 2(2019)
Issue Display:: Volume 186, Issue 2 (2019)
Year:: 2019
Volume:: 186
Issue:: 2
Issue Sort Value:: 2019-0186-0002-0000
Page Start:: 380
Page End:: 382
Publication Date:: 2019-04-07
Subjects:: chronic lymphocytic leukaemia -- immunotherapy -- ROR1 -- bispecific T cell engager -- ibrutinib
Hematology -- Periodicals
Blood -- Diseases -- Periodicals
616.15
Journal URLs:: http://www.blacksci.co.uk/%7Ecgilib/jnlpage.bin?Journal=bjh&File=bjh&Page=aims ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjh.15911 ↗
Languages:: English
ISSNs:: 0007-1048
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2309.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 11254.xml